Eton Pharmaceuticals, Inc.ETONNASDAQ
Loading
Year-over-year operating cash flow growth rate
Percentile
P6
Near historical low
vs 3Y Ago
-1.1x
Contraction
Streak
3 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | -283.56% |
| Q3 2025 | 51.10% |
| Q2 2025 | 280.81% |
| Q1 2025 | 373.20% |
| Q4 2024 | -125.91% |
| Q3 2024 | 135.22% |
| Q2 2024 | 150.75% |
| Q1 2024 | -739.02% |
| Q4 2023 | -55.67% |
| Q3 2023 | -87.71% |
| Q2 2023 | 558.85% |
| Q1 2023 | -154.51% |
| Q4 2022 | 266.76% |
| Q3 2022 | -169.20% |
| Q2 2022 | 101.23% |
| Q1 2022 | 123.90% |
| Q4 2021 | -73.46% |
| Q3 2021 | -699.46% |
| Q2 2021 | -109.93% |
| Q1 2021 | 151.73% |
| Q4 2020 | -40.99% |
| Q3 2020 | -78.55% |
| Q2 2020 | 60.47% |
| Q1 2020 | -87.55% |
| Q4 2019 | -19.69% |
| Q3 2019 | 23.38% |
| Q2 2019 | 37.99% |
| Q1 2019 | -281.45% |
| Q4 2018 | 22.63% |
| Q3 2018 | -2.92% |
| Q2 2018 | -20.43% |
| Q1 2018 | 46.02% |
| Q4 2017 | 0.00% |
| Q3 2017 | 100.00% |
| Q2 2017 | 0.00% |